Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.
暂无分享,去创建一个
A. Makarov | V. Mitkevich | A. Ivanov | S. Radko | L. Kurbatov | Y. Mezentsev | S. Kozin | Y. Kiseleva | S. Khmeleva
[1] A. Makarov,et al. Interplay of histidine residues of the Alzheimer’s disease Aβ peptide governs its Zn-induced oligomerization , 2016, Scientific Reports.
[2] M. Mann,et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA , 2016, Science.
[3] G. Kim,et al. The Role of Oxidative Stress in Neurodegenerative Diseases , 2015, Experimental neurobiology.
[4] A. Makarov,et al. Tyrosine Based Electrochemical Analysis of Amyloid-β Fragment (1-16) Binding to Metal(II) Ions , 2015 .
[5] N. Andreasen,et al. Pathways to Alzheimer's disease , 2014, Journal of internal medicine.
[6] A. Bush,et al. Metallostasis in Alzheimer's disease. , 2013, Free radical biology & medicine.
[7] P. Faller,et al. Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide. , 2013, Inorganic chemistry.
[8] A. Barrantes,et al. Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides. , 2013, International journal of biological macromolecules.
[9] P. Tsvetkov,et al. Zinc-induced interaction of the metal-binding domain of amyloid-β peptide with DNA. , 2013, Journal of Alzheimer's disease : JAD.
[10] Veer Bala Gupta,et al. Studies on the mechanism of the DNA nicking property of amyloid-β40: implications in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[11] T. Bayer,et al. Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic models. , 2012, Life sciences.
[12] Ruth Nussinov,et al. Metal binding sites in amyloid oligomers: Complexes and mechanisms , 2012 .
[13] A. Barrantes,et al. Alzheimer's disease amyloid peptides interact with DNA, as proved by surface plasmon resonance. , 2012, Current Alzheimer research.
[14] L. Hemmingsen,et al. Rapid exchange of metal between Zn(7)-metallothionein-3 and amyloid-β peptide promotes amyloid-related structural changes. , 2012, Biochemistry.
[15] P. Tsvetkov,et al. NMR solution structure of rat aβ(1-16): toward understanding the mechanism of rats' resistance to Alzheimer's disease. , 2012, Biophysical journal.
[16] D. Bhowmik,et al. Zn(++) binding disrupts the Asp(23)-Lys(28) salt bridge without altering the hairpin-shaped cross-β Structure of Aβ(42) amyloid aggregates. , 2011, Biophysical journal.
[17] Bryan Maloney,et al. The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif. , 2011, Gene.
[18] P. Tsvetkov,et al. Zinc-induced dimerization of the amyloid-β metal-binding domain 1-16 is mediated by residues 11-14. , 2011, Molecular bioSystems.
[19] L. Jungbauer,et al. Preparing synthetic Aβ in different aggregation states. , 2011, Methods in molecular biology.
[20] Alexander A. Makarov,et al. Minimal Zn(2+) binding site of amyloid-β. , 2010, Biophysical journal.
[21] Gabriele Meloni,et al. Zinc release of Zn₇-metallothionein-3 induces fibrillar type amyloid-β aggregates. , 2010, Metallomics : integrated biometal science.
[22] X. Qu,et al. Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form. , 2010, Chemical communications.
[23] Bryan Maloney,et al. Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications , 2010, Experimental Neurology.
[24] Ruth Nussinov,et al. Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states , 2010, Proceedings of the National Academy of Sciences.
[25] E. Capetillo-Zarate,et al. Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.
[26] J. S. Jiménez. Protein-DNA interaction at the origin of neurological diseases: a hypothesis. , 2010, Journal of Alzheimer's disease : JAD.
[27] Y. Ohyagi. Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease. , 2008, Current Alzheimer research.
[28] Valerio Frazzini,et al. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer’s disease , 2008, Experimental Gerontology.
[29] A. Cuello,et al. Impact of Intracellular β-Amyloid in Transgenic Animals and Cell Models , 2008, Neurodegenerative Diseases.
[30] Charles P. Fontaine,et al. Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. , 2008, American journal of physiology. Cell physiology.
[31] R. Ravid,et al. First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1–42) and aluminum , 2004, Journal of Molecular Neuroscience.
[32] X. Qu,et al. Time-Dependent DNA Condensation Induced by Amyloid β-Peptide , 2007 .
[33] A. Barrantes,et al. Interaction between Alzheimer's Abeta1-42 peptide and DNA detected by surface plasmon resonance. , 2007, Journal of Alzheimer's disease : JAD.
[34] A. Mazur,et al. Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro Aging* , 2006, Journal of Biological Chemistry.
[35] T. Tabira,et al. Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease , 2005 .
[36] E. Iseki,et al. Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias , 2004, Neurological research.
[37] C. Suschek,et al. Regulation of zinc homeostasis by inducible NO synthase-derived NO: Nuclear metallothionein translocation and intranuclear Zn2+ release , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Tikkanen,et al. Cytosolic and nuclear aggregation of the amyloid β-peptide following its expression in the endoplasmic reticulum , 2002, Histochemistry and Cell Biology.
[39] M. D'Andrea,et al. Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease , 2002, Neuroscience.
[40] P. A. Peterson,et al. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease , 2001, Histopathology.
[41] P. Fraser,et al. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. , 2000, European journal of biochemistry.
[42] B. Shin,et al. Detection of β-Amyloid Peptide Aggregation Using DNA Electrophoresis , 2000 .
[43] G. Lees,et al. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya , 1998, Brain Research.
[44] D. Selkoe,et al. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. , 1997, The Journal of biological chemistry.
[45] Zhi-Xin Wang,et al. A novel two‐site binding equation presented in terms of the total ligand concentration , 1996, FEBS letters.
[46] D. Williams,et al. Nuclear and cytoplasmic localization of the beta-amyloid peptide (1-43) in transfected 293 cells. , 1996, Biochemical and biophysical research communications.
[47] H. Wiśniewski,et al. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.